Agrosaf Pharmaceuticals shifts to direct B2B model in Indian drug distribution
9 reports, 1 independent
Updated Fri 00:00
Mostly repetition
Reached 9 outlets in its first 24 hours
- Reports
- 9
- Developments
- 1
- Repetition
- 89%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Agrosaf Pharmaceuticals is implementing a business model focused on direct connections with pharmacy owners across India. The company is reducing unnecessary intermediaries in the traditional pharmaceutical distribution chain. Kushagra Agarwal, Managing Director of BM Group and Agrosaf Pharmaceuticals, is leading these technology-led growth initiatives.
From aninews.in
Why it matters
The shift addresses the demand from healthcare retailers for better margins, wider product availability, and digital solutions. By moving to a direct B2B approach, Agrosaf aims to create a more accessible and efficient ecosystem for healthcare retailers.
From aninews.in
Who's involved
- Kushagra AgarwalManaging Director of BM Group and Agrosaf Pharmaceuticals, driving business development and technology-led growth.
Keep exploring
The entities involved
-
Kushagra Agarwal
researcher
Nothing else this week.